TNF and gastrointestinal disease: Immunocompromise in our patients was primarily associated with receipt of a solid organ transplant or treatment with TNF antagonists and other disease-modifying anti-rheumatic drugs for rheumatologic or gastrointestinal diseases, reflecting the usual spectrum of immunocompromised patients seen in many hospitals today.